Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
8
NCT00896077
Subcutaneous Administration of Lisofylline to Healthy Normal Subjects and Subjects With Type 1 Diabetes
Phase: Phase 1/2
Role: Lead Sponsor
Start: May 31, 2009
Completion: Dec 31, 2009